Qiagen has identified Parse Biosciences’ technology as complementary to its sample technology and bioinformatic businesses.

Watchmaker Genomics today announced the launch of TAPS+, a next-generation technology that unites genetic and epigenetic ...

Whole-genome sequencing (WGS) of tumor and germline can generate actionable molecular insights that can guide precision medicine efforts in salivary gland cancer (SGC), according to a new study in JCO ...

Recognized in the Biotechnology category of the 2025 Top Innovations contest, small Cas12l nucleases are versatile, ...

Invited presentation followed by panel discussion on the next wave of innovation in immunotherapy of cancer: Paul Peter Tak, M.D., Ph.D., ...

According to one of the authors, additional work is needed to validate findings in a larger prospective study ‘and to apply ...

MiDOG Expands Scientific Advisory Board with the Appointment of Dr. Curtis Huttenhower, Dr. Micah Kohles, and Dr. Krista A. Keller Leaders in microbiome science, clinical practice, and exotic animal ...

For managed care organizations and health systems, the recommendations strongly advocated highly selective use of NGS. Routine, nonselective NGS for all sarcoma patients is not justified. Instead, ...

Pharmacists are integral to oncology care, optimizing treatment plans, managing adverse effects, and supporting precision medicine through collaborative practice agreements.

Countable Labs has launched Countable 10, a PCR instrument capable of detecting 10 distinct fluorophores within a single reaction.

New methods of testing tissue and plasma beyond next-generation sequencing (NGS) could be used to deliver the best ...

Clonal hematopoiesis of indeterminate potential (CHIP) is a known risk factor for coronary artery disease, though its precise role in disease progression continues to emerge. This study leverages ...